Synergy Spine Solutions announces US$30 million financing

1 minute read
31 January 2024

On January 31, 2024, Synergy Spine Solutions Inc. announced that it had closed on a significant equity financing of US$30 million. The Series A financing was led by a new institutional investor, Amzak Health, and joined by other investors.

Synergy Spine Solutions is an innovative medical device developer focused on artificial cervical disc replacement, with locations in Cambridge, Ontario, and Louisville, Colorado.
Proceeds from the financing will be used to complete enrollment of Synergy's U.S. IDE 2-level clinical trial, continue patient follow-up on both the 1-level and 2-level clinical trials, submit anticipated Pre-Market Approval applications to the FDA, as well as to support continued commercialization in markets outside the United States.
Gowling WLG advised Synergy Spine Solutions with respect to this financing with a corporate team led by Tom Hunter and consisting of John Durdan, Radhika Vaidyanathan, Irena Kramer, Lidia Imbrogno and Kulvinder Samrai, assisted by law clerks John Bedard and Cynthia Thorne.

NOT LEGAL ADVICE. Information made available on this website in any form is for information purposes only. It is not, and should not be taken as, legal advice. You should not rely on, or take or fail to take any action based upon this information. Never disregard professional legal advice or delay in seeking legal advice because of something you have read on this website. Gowling WLG professionals will be pleased to discuss resolutions to specific legal concerns you may have.